.STUDY EMPHASIZE.06 August 2024.
A sizable randomized regulated test with cisgender ladies highlights the problems of obedience to a day-to-day oral preexposure prevention regiment and also demonstrates that twice-yearly treatment of lenacapavir can preserve effective HIV deterrence amounts over 6 months.